HS was recognized as a neuropathologic feature associated with dementia in 1994 (102), and the association between HS and TDP-43 proteinopathy was first reported in 2007 (103); both of these advances were accomplished by Dr Dennis Dickson and colleagues at the Mayo Clinic (Fig. 1). Here, TARDBP is linked to proteostasis deficiencies.